AI hunts for clues to personalize IBD treatment

NCT ID NCT05733702

Summary

This study aims to use artificial intelligence (AI) to analyze health data from people with Crohn's disease or ulcerative colitis (IBD) who are changing their treatment. Researchers will collect information from about 800 participants over up to five years to find patterns that can predict how well a treatment will work for an individual. The goal is to help doctors make better, more personalized treatment decisions in the future.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Hospitalier de Luxembourg (CHL)

    RECRUITING

    Luxembourg, L-1210, Luxembourg

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.